Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment.
Sumit K SubudhiBilal A SiddiquiAna M AparicioShalini S YadavSreyashi BasuHong ChenSonali JindalRebecca S Slack TidwellAshwin VarmaChristopher J LogothetisJames P AllisonPaul G CornPadmanee SharmaPublished in: Journal for immunotherapy of cancer (2022)
NCT03204812.